Marco Giorgio Baroni (Marco G Baroni, M G Baroni)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 21

Top Topics

Insulin Resistance

Bariatric Surgery

Top Venues

International journal of molecular sciences

Journal of endocrinological investigation

Diabetes/metabolism research and reviews

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Pompea Antonia Baldassarre, Giulia Di Dalmazi, Sara Coluzzi, Federica Carrieri, Fabrizio Febo, Giorgia Centorame, Piergiuseppe Cassino, Luigi Piacentino, Marco Giorgio Baroni, Agostino Consoli, Gloria Formoso
Oral Semaglutide in Routine Clinical Practice: Characteristics of People with Type 2 Diabetes Started on the Drug and Changes in Their Clinical Parameters after 24 Weeks of Treatment. Journal of clinical medicine 13 (11) (2024)
Maria Pompea Antonia Baldassarre, Giulia Di Dalmazi, Sara Coluzzi, Federica Carrieri, Fabrizio Febo, Giorgia Centorame, Piergiuseppe Cassino, Luigi Piacentino, Marco Giorgio Baroni, Agostino Consoli, Gloria Formoso
Oral Semaglutide in Routine Clinical Practice: Characteristics of People with Type 2 Diabetes Started on the Drug and Changes in Their Clinical Parameters after 24 Weeks of Treatment. Journal of clinical medicine 13 (11) (2024)
Ilaria Barchetta, Flavia Agata Cimini, Federica Sentinelli, Caterina Chiappetta, Claudio Di Cristofano, Gianfranco Silecchia, Frida Leonetti, Marco Giorgio Baroni, Maria Gisella Cavallo
Reduced Lipopolysaccharide-Binding Protein (LBP) Levels Are Associated with Non-Alcoholic Fatty Liver Disease (NAFLD) and Adipose Inflammation in Human Obesity. International journal of molecular sciences 24 (24) (2023)
Federica Sentinelli, Ilaria Barchetta, Flavia Agata Cimini, Sara Dule, Diego Bailetti, Efisio Cossu, Arcangelo Barbonetti, Maria Totaro, Olle Melander, Maria Gisella Cavallo, Marco Giorgio Baroni
Neurotensin Gene rs2234762 C>G Variant Associates with Reduced Circulating Pro-NT Levels and Predicts Lower Insulin Resistance in Overweight/Obese Children. International journal of molecular sciences 24 (7) (2023)
Ilaria Barchetta, Flavia Agata Cimini, Federica Sentinelli, Caterina Chiappetta, Claudio Di Cristofano, Gianfranco Silecchia, Frida Leonetti, Marco Giorgio Baroni, Maria Gisella Cavallo
Reduced Lipopolysaccharide-Binding Protein (LBP) Levels Are Associated with Non-Alcoholic Fatty Liver Disease (NAFLD) and Adipose Inflammation in Human Obesity. International journal of molecular sciences 24 (24) (2023)
Valentina Maria Cambuli, Marco Giorgio Baroni
Intelligent Insulin vs. Artificial Intelligence for Type 1 Diabetes: Will the Real Winner Please Stand Up? International journal of molecular sciences 24 (17) (2023)
Sara Dule, Ilaria Barchetta, Flavia Agata Cimini, Giulia Passarella, Arianna Dellanno, Tiziana Filardi, Vittorio Venditti, Enrico Bleve, Diego Bailetti, Elisabetta Romagnoli, Susanna Morano, Marco Giorgio Baroni, Maria Gisella Cavallo
Reduced High-Density Lipoprotein Cholesterol Is an Independent Determinant of Altered Bone Quality in Women with Type 2 Diabetes. International journal of molecular sciences 24 (7) (2023)
G Formoso, Marco Giorgio Baroni
Semaglutide in routine clinical practice: interesting news from real-world evidence. Journal of endocrinological investigation 45 (8) (2022)
Diego Bailetti, Federica Sentinelli, Sabrina Prudente, Flavia Agata Cimini, Ilaria Barchetta, Maria Totaro, Alessia Di Costanzo, Arcangelo Barbonetti, Frida Leonetti, Maria Gisella Cavallo, Marco Giorgio Baroni
Deep Resequencing of 9 Candidate Genes Identifies a Role for ARAP1 and IGF2BP2 in Modulating Insulin Secretion Adjusted for Insulin Resistance in Obese Southern Europeans. International journal of molecular sciences 23 (3) (2022)
Ilaria Barchetta, Marco Giorgio Baroni, Olle Melander, Maria Gisella Cavallo
New Insights in the Control of Fat Homeostasis: The Role of Neurotensin. International journal of molecular sciences 23 (4) (2022)
G Iacobellis, Marco Giorgio Baroni
Cardiovascular risk reduction throughout GLP-1 receptor agonist and SGLT2 inhibitor modulation of epicardial fat. Journal of endocrinological investigation (2021)
I Barchetta, S Dule, L Bertoccini, F A Cimini, F Sentinelli, D Bailetti, G Marini, A Barbonetti, S Loche, E Cossu, M G Cavallo, Marco Giorgio Baroni
The single-point insulin sensitivity estimator (SPISE) index is a strong predictor of abnormal glucose metabolism in overweight/obese children: a long-term follow-up study. Journal of endocrinological investigation (2021)
Flavia Agata Cimini, Ilaria Barchetta, Gea Ciccarelli, Frida Leonetti, Gianfranco Silecchia, Caterina Chiappetta, Claudio Di Cristofano, Danila Capoccia, Laura Bertoccini, Valentina Ceccarelli, Raffaella Carletti, Antonio Fraioli, Marco Giorgio Baroni, Sergio Morini, Maria Gisella Cavallo
Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease. Diabetes/metabolism research and reviews 37 (1) (2020)
Federica Sentinelli, Laura Bertoccini, Michela Incani, Maria Grazia Pani, Francesco David, Diego Bailett, Alessandra Boi, Ilaria Barchetta, Flavia Agata Cimini, Anna Camilla Mannino, Andrea Lenzi, Maria Gisella Cavallo, Sandro Loche, Efisio Cossu, Marco Giorgio Baroni
Association of Apelin Levels in Overweight-obese Children with Pubertal Development, but Not with Insulin Sensitivity: 6.5 Years Follow up Evaluation. Endocrine research 45 (4) (2020)
I Barchetta, F A Cimini, G Ciccarelli, Marco Giorgio Baroni, M G Cavallo
Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation. Journal of endocrinological investigation 42 (11) (2019)
L Bertoccini, F Sentinelli, M Incani, D Bailetti, F A Cimini, I Barchetta, A Lenzi, M G Cavallo, E Cossu, Marco Giorgio Baroni
Circulating miRNA-375 levels are increased in autoantibodies-positive first-degree relatives of type 1 diabetes patients. Acta diabetologica 56 (6) (2019)
Ilaria Barchetta, F A Cimini, R De Gioannis, G Ciccarelli, L Bertoccini, A Lenzi, Marco Giorgio Baroni, M G Cavallo
Procollagen-III peptide identifies adipose tissue-associated inflammation in type 2 diabetes with or without nonalcoholic liver disease. Diabetes/metabolism research and reviews 34 (5) (2018)
E Cossu, M Incani, M G Pani, G Gattu, C Serafini, A Strazzera, L Bertoccini, F A Cimini, I Barchetta, M G Cavallo, Marco Giorgio Baroni
Presence of diabetes-specific autoimmunity in women with gestational diabetes mellitus (GDM) predicts impaired glucose regulation at follow-up. Journal of endocrinological investigation 41 (9) (2018)
D Bailetti, L Bertoccini, R M Mancina, I Barchetta, D Capoccia, E Cossu, A Pujia, A Lenzi, F Leonetti, M G Cavallo, S Romeo, Marco Giorgio Baroni
ANGPTL4 gene E40K variation protects against obesity-associated dyslipidemia in participants with obesity. Obesity science & practice 5 (1) (2018)
Laura Bertoccini, Federica Sentinelli, Frida Leonetti, Diego Bailetti, Danila Capoccia, Flavia A Cimini, Ilaria Barchetta, Michela Incani, Andrea Lenzi, Efisio Cossu, M Gisella Cavallo, Marco Giorgio Baroni
The vitamin D receptor functional variant rs2228570 (C>T) does not associate with type 2 diabetes mellitus. Endocrine research 42 (4) (2017)
M Incani, C Serafini, C Satta, L Perra, F Scano, P Frongia, R Ricciardi, C Ripoli, M Soro, A Strazzera, S Zampetti, R Buzzetti, M G Cavallo, E Cossu, Marco Giorgio Baroni
High prevalence of diabetes-specific autoimmunity in first-degree relatives of Sardinian patients with type 1 diabetes. Diabetes/metabolism research and reviews 33 (3) (2016)